2007
DOI: 10.1016/j.gie.2007.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Treatment of Esophageal Varices in Cirrhotic Patients: Band Ligation Versus Cyanoacrylate Injection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…For example, in the USA an estimated 18 170 cases of esophageal cancer were diagnosed in 2013, and 15 450 deaths are expected from the disease [8]. The guidelines also recommend that patients with medium or large varices (grades III, IV) be treated with a combination therapy of β-blockers and endoscopic variceal band ligation [13][14][15][16][17]. In the same context, almost half of the patients with hepatic cirrhosis have esophageal varices, and one-third of all patients with varices will develop variceal hemorrhage, a major cause of morbidity and mortality in patients with liver cirrhosis.…”
Section: Discussionmentioning
confidence: 99%
“…For example, in the USA an estimated 18 170 cases of esophageal cancer were diagnosed in 2013, and 15 450 deaths are expected from the disease [8]. The guidelines also recommend that patients with medium or large varices (grades III, IV) be treated with a combination therapy of β-blockers and endoscopic variceal band ligation [13][14][15][16][17]. In the same context, almost half of the patients with hepatic cirrhosis have esophageal varices, and one-third of all patients with varices will develop variceal hemorrhage, a major cause of morbidity and mortality in patients with liver cirrhosis.…”
Section: Discussionmentioning
confidence: 99%
“…Santos et al [36] prospectively compared EVL with N-butylcyanoacrylate ES in 38 patients, showing no significant differences in rates of variceal eradication (90% versus 72%, P ¼ .39), mortality (55% versus 56%, P ¼ .52), or major complications (5% versus 17%, P ¼ .32). Two additional randomized controlled trials specifically comparing EVL and ES in acute bleeding esophageal varices [32,37] showed that both modalities effectively arrested active bleeding.…”
Section: Discussion Of Procedures By Variantmentioning
confidence: 99%
“…Santos, et al [8] Literature review Secondary prophylaxis is indicated for all patients with bleeding from esophageal varices. In adults, the method considered to be the most effective is the combined use of beta-blocker and LE.…”
Section: Languagementioning
confidence: 99%